papuamide A

from marine sponge of genus Theonella; structure in first source

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

1.	Virus Diseases (Viral Diseases) 01/01/2008 - "Time delayed addition studies with the pseudotyped viruses show that papuamide A inhibits viral infection only at the initial stage of the viral life cycle. "
2.	Vesicular Stomatitis 01/01/2008 - "Furthermore, papuamide A was able to inhibit HIV pseudotype viruses expressing envelope glycoproteins from vesicular stomatitis virus or amphotropic murine leukemia virus indicating the mechanism of viral entry inhibition is not HIV-1 envelope glycoprotein specific. "
3.	Infections 01/01/2008 - "We show here that papuamide A acts as an entry inhibitor, preventing human immunodeficiency virus infection of host cells and that this inhibition is not specific to R5 or X4 tropic virus. "
4.	Hypersensitivity (Allergy) 01/01/2016 - "However, the neo1-1(ts) and neo1-2(ts) mutants display a loss of PS and PE asymmetry at permissive growth temperatures as measured by hypersensitivity to pore-forming toxins that target PS (papuamide A) or PE (duramycin) exposed in the extracellular leaflet. "

1.	Glycoproteins (Glycoprotein)
2.	duramycin